Apnea: Clinical Trials

13 trials for Apnea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 terminated. 13 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Terminated 13
Phase 33Terminated 3
Phase 11Terminated 1

Follow Apnea: new trials by email Literature Review of Apnea trials Research Report on Apnea

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery
Danavorexton, Placebo - Sleep Apnea
Phase 2TerminatedTakeda412023-05-112025-09-16
Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea
Metformin + PAP, Placebo oral capsule + PAP - Sleep Apnea, Obstructive
Phase 1 / Phase 2TerminatedPennington Biomedical Research Center162021-01-282023-01-19
Validation of Sleep Apnea Screening Device Phase II
Obstructive Sleep Apnea Screening Device - Obstructive Sleep Apnea
Phase 2TerminatedUniversity of Michigan302017-11-142023-01-27
Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea
Ketamine, Control - Sleep Apnea, Obstructive Sleep Apnea
Phase 2 / Phase 3TerminatedUniversity of Alabama at Birmingham92016-06-022019-12-19
OneShot Renal Denervation Registry
OneShot Ablation System - Hypertension, Heart Failure
Phase 2 / Phase 3TerminatedMedtronic Endovascular512014-07-012015-09-02
Efficacy of AerosalĀ® in the Treatment of Sub-Obstructive Adenotonsillar Hypertrophy and Related Diseases
Halotherapy, Placebo - Sleep Apnea, Obstructive
Phase 2TerminatedTecno Sun SRL452012-02-012012-11-08
Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea
Inhalation of low concentration of CO2 - Apnea of Prematurity
Phase 2 / Phase 3TerminatedUniversity of Manitoba72011-10-012015-02-19
Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients
AVE0657, placebo - Heart Failure, Sleep Apnea Syndromes
Phase 2TerminatedSanofi82008-06-012009-05-01
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
Atorvastatin treatment, CPAP device, sham CPAP treatment - Obstructive Sleep Apnea Syndrome
Phase 2TerminatedUniversity Hospital, Grenoble542008-05-012013-09-24
Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)
Comparator: MK0249, Comparator: placebo, Comparator: modafinil - Sleep Apnea, Obstructive, Hypopnea Syndrome
Phase 2TerminatedMerck Sharp & Dohme LLC1252008-02-012015-05-13
A Trial of Infant Flow Biphasic Nasal Continuous Airway Pressure (NCPAP) Versus Infant Flow NCPAP for the Facilitation of Extubation in Infants </= 1250 Grams
Biphasic Infant flow NCPAP, CPAP - Infant, Premature, Diseases, Bronchopulmonary Dysplasia
Phase 2TerminatedMount Sinai Hospital, Canada1362006-04-012009-05-05
Effect of Fenofibrate on Sleep Apnea Syndrome
Placebo, Fenofibrate - Dyslipidemia, Sleep Apnea Syndrome
Phase 2TerminatedSolvay Pharmaceuticals342005-09-012009-07-22
Sleep Apnea Treatment After Stroke (SATS)
continuous positive airway pressure or CPAP, sham CPAP - Obstructive Sleep Apnea, Stroke
Phase 2TerminatedUniversity of Michigan322004-09-012013-03-11

Narrower conditions

Sleep Apnea, Obstructive (8)  ·  Sleep Apnea Syndromes (6)  ·  Heart Failure (2)  ·  Bronchopulmonary Dysplasia (1)  ·  Cheyne-Stokes Respiration (1)  ·  Diabetes Mellitus (1)  ·  Disorders of Excessive Somnolence (1)  ·  Dyslipidemias (1)  ·  Hypertension (1)  ·  Infant, Premature, Diseases (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Postoperative Complications (1)  ·  Stroke (1)

Broader conditions

Respiration Disorders (13)  ·  Respiratory Tract Diseases (13)  ·  Dyssomnias (11)  ·  Nervous System Diseases (11)  ·  Sleep Disorders, Intrinsic (11)  ·  Sleep Wake Disorders (11)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Sleep Apnea Syndromes (5)  ·  Signs and Symptoms (4)  ·  Cardiovascular Diseases (3)  ·  Signs and Symptoms, Respiratory (3)  ·  Heart Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

Continuous Positive Airway Pressure (1)  ·  Fenofibrate (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Ketamine (1)  ·  Metformin (1)  ·  TAK-925 (1)

Sponsors

University of Michigan (2)  ·  Medtronic Endovascular (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Mount Sinai Hospital, Canada (1)  ·  Pennington Biomedical Research Center (1)  ·  Sanofi (1)  ·  Solvay Pharmaceuticals (1)  ·  Takeda (1)  ·  Tecno Sun SRL (1)  ·  University Hospital, Grenoble (1)  ·  University of Alabama at Birmingham (1)  ·  University of Manitoba (1)

Countries

United States (5)  ·  France (3)  ·  Canada (2)  ·  Italy (2)  ·  Germany (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Devin Brown, MD, MS (1)  ·  Jack Kalbfleisch, PhD (1)  ·  Karel O'Brien, MB, FRCPC (1)  ·  Lewis Morgenstern, MD (1)  ·  Matteo Gelardi, MD (1)  ·  Peter A Nagi, MD (1)  ·  Prachi Singh, PhD (1)  ·  Ruben E Alvaro, MD (1)

Results publications

PMID 20297950, PMID 21784661, PMID 22475409, PMID 23920422, PMID 24041858, PMID 25221387, PMID 26567858, PMID 38346816

NIH funding

2005 (1), P30DK072476 (1)